Evidence map›Paper›PMID 41039727›Full record

ArticleThe journal of physical chemistry letters2025

Electron-Induced Fragmentation of 5-Iodouridine: Implications for Enhanced Radiotherapy.

Janina Kopyra, Paulina Wierzbicka, Hassan Abdoul-Carime

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Janina KopyraFaculty of Sciences, Siedlce University, 3 Maja 54, 08-110 Siedlce, Poland.ORCID 0000-0001-6703-4297
Paulina WierzbickaFaculty of Sciences, Siedlce University, 3 Maja 54, 08-110 Siedlce, Poland.
Hassan Abdoul-CarimeUniversite Claude Bernard Lyon 1, CNRS/IN2P3, UMR5822, Institut de Physique des 2 InfinisF-69003 Lyon, Villeurbanne France.ORCID 0000-0002-9382-4310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Iodouridine is a known and potentially efficient radiosensitizer; however, it has not been considered for clinical use because of its poor metabolic incorporation into DNA. Recent development of a novel pro-drug, ropidoxuridine, has improved the bioavailability of this halogenated nucleoside, although the exact mechanism of its radiosensitizing action remains not fully elucidated. Here, we demonstrate that low-energy electrons─abundantly generated along radiation tracks─efficiently dissociate the halogenated nucleoside via the primary pathway (99%), producing an iodine anion and a uridine-yl

Indexed as

ElectronsIdoxuridineRadiation-Sensitizing AgentsIdoxuridineRadiation-Sensitizing Agents

Identifiers

PMID41039727
PMCPMC12536442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.